Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature.
(2022) Acta Clinica Belgica — Vol. 77, n° 1, p. 113-117 (2022)
Files
2020_Oriot_Acta_Clin_Belg.pdf
Postprint
Open Access - Adobe PDF
- 618.67 KB
Details
- Authors
- Abstract
- OBJECTIVE: Recent publications on Coronavirus Disease-2019 (COVID-19) report that diabetic people with or without co-morbidities are at higher risk of developing severe and/or fatal illnesses. METHOD AND RESULT: We report the first case of a 60-year-old man with a 27-year history of type 1 diabetes mellitus, infected by SARS-CoV-2 presenting with an euglycaemic ketoacidosis and an acute respiratory distress syndrome. CONCLUSION: This case report reminds us of the importance of adjusting more recent glucose-lowering drugs, including sodium-glucose cotransporter 2 inhibitors, in the overall management of type 1 diabetic individuals during the ongoing COVID-19 outbreak.
- Affiliations
Citations
Oriot, P., & Hermans, M. (2022). Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature. Acta Clinica Belgica, 77(1), 113-117. https://doi.org/10.1080/17843286.2020.1780390 (Original work published 2022)